NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 279 filers reported holding NEOGENOMICS INC in Q3 2023. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $5,246,614 | +340.0% | 326,485 | +376.7% | 0.01% | +300.0% |
| Q1 2023 | $1,192,463 | +4988.8% | 68,493 | +2600.8% | 0.00% | – |
| Q4 2022 | $23,433 | -89.3% | 2,536 | -90.0% | 0.00% | -100.0% |
| Q3 2022 | $218,000 | -98.3% | 25,309 | -98.3% | 0.00% | -97.6% |
| Q2 2022 | $12,471,000 | +295.5% | 1,530,141 | +489.6% | 0.04% | +310.0% |
| Q1 2022 | $3,153,000 | -76.7% | 259,509 | -34.4% | 0.01% | -78.3% |
| Q4 2021 | $13,507,000 | +90.6% | 395,881 | +169.4% | 0.05% | +31.4% |
| Q1 2021 | $7,086,000 | +464.6% | 146,931 | +242.3% | 0.04% | +400.0% |
| Q4 2019 | $1,255,000 | -39.4% | 42,922 | -54.5% | 0.01% | -46.2% |
| Q2 2019 | $2,071,000 | +275.9% | 94,386 | +250.6% | 0.01% | +225.0% |
| Q1 2019 | $551,000 | +308.1% | 26,918 | +60.5% | 0.00% | +300.0% |
| Q2 2016 | $135,000 | +11.6% | 16,772 | -25.1% | 0.00% | 0.0% |
| Q2 2015 | $121,000 | +23.5% | 22,390 | +6.6% | 0.00% | 0.0% |
| Q1 2015 | $98,000 | – | 21,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KOPP INVESTMENT ADVISORS LLC | 396,327 | $8,109,000 | 6.56% |
| Cowen Prime Services LLC | 584,766 | $11,964,000 | 6.20% |
| 1492 Capital Management LLC | 269,488 | $5,514,000 | 4.67% |
| First Light Asset Management, LLC | 1,604,611 | $32,830,000 | 4.27% |
| PERKINS CAPITAL MANAGEMENT INC | 264,650 | $5,415,000 | 3.56% |
| FALCON POINT CAPITAL, LLC | 219,992 | $4,501,000 | 2.45% |
| Granite Investment Partners, LLC | 1,764,090 | $36,093,000 | 2.05% |
| Ranger Investment Management | 1,209,535 | $24,747,000 | 1.79% |
| EMERALD ADVISERS, LLC | 1,878,901 | $38,442,000 | 1.56% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,875,759 | $38,378,000 | 1.54% |